Tech Company Financing Transactions

Acorda Therapeutics Funding Round

Acorda Therapeutics secured a $55.3 million funding round on 5/9/2003. Backers included Easton Capital, Cross Atlantic Capital Partners and JPMorgan Partners.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

420 Saw Mill River Rd.
Ardsley, NY 10502
USA

Phone

(914) 347-4300

Website

www.acorda.com

Email Address

[email protected]

Overview

Since 1995, Acorda has been a world leading biotechnology company developing multiple sclerosis (MS) and spinal cord injury treatments (SCI).

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ron Cohen

        

Chief Medical Officer

Burkhard Blank

        

Chief Operating Officer

David Lawrence

        

Chief Scientific Officer

Andrew Blight

        

VP - General Counsel

Jane Wasman

        

VP - Human Resources

Denise Duca

        

VP - Regulatory Affairs

Peter Carbone

        

Browse more venture capital transactions:

Prev: 5/6/2003: TranS1 venture capital transaction
Next: 5/12/2003: Redline Networks venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary